HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 60 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,406,714 | -6.9% | 2,606,247 | 0.0% | 9.36% | +47.8% |
| Q2 2023 | $91,713,832 | +7.8% | 2,606,247 | 0.0% | 6.33% | +7.2% |
| Q1 2023 | $85,093,965 | +59156.0% | 2,606,247 | 0.0% | 5.90% | -64.3% |
| Q4 2022 | $143,604 | -99.9% | 2,606,247 | -23.4% | 16.53% | -0.6% |
| Q3 2022 | $150,598,000 | -24.6% | 3,400,261 | -16.9% | 16.63% | -17.1% |
| Q2 2022 | $199,654,000 | -10.2% | 4,093,785 | -10.4% | 20.05% | +30.9% |
| Q1 2022 | $222,338,000 | +6.8% | 4,570,148 | -6.4% | 15.31% | +21.9% |
| Q4 2021 | $208,268,000 | +11.2% | 4,884,341 | 0.0% | 12.56% | +49.4% |
| Q3 2021 | $187,217,000 | +46.3% | 4,884,341 | +7.7% | 8.41% | +51.7% |
| Q2 2021 | $128,004,000 | -14.6% | 4,534,341 | 0.0% | 5.54% | +5.2% |
| Q1 2021 | $149,815,000 | -8.6% | 4,534,341 | 0.0% | 5.26% | -28.0% |
| Q4 2020 | $163,916,000 | +6.6% | 4,534,341 | 0.0% | 7.32% | -17.7% |
| Q3 2020 | $153,714,000 | – | 4,534,341 | – | 8.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |